RT Journal Article
T1 Evaluation of the Kinetics of Antibody Response to COVID-19 Vaccine in Solid Organ Transplant Recipients: The Prospective Multicenter ORCHESTRA Cohort.
A1 Giannella, Maddalena
A1 Righi, Elda
A1 Pascale, Renato
A1 Rinaldi, Matteo
A1 Caroccia, Natascia
A1 Gamberini, Chiara
A1 Palacios-Baena, Zaira R
A1 Caponcello, Giulia
A1 Morelli, Maria Cristina
A1 Tamè, Mariarosa
A1 Busutti, Marco
A1 Comai, Giorgia
A1 Potena, Luciano
A1 Salvaterra, Elena
A1 Feltrin, Giuseppe
A1 Cillo, Umberto
A1 Gerosa, Gino
A1 Cananzi, Mara
A1 Piano, Salvatore
A1 Benetti, Elisa
A1 Burra, Patrizia
A1 Loy, Monica
A1 Furian, Lucrezia
A1 Zaza, Gianluigi
A1 Onorati, Francesco
A1 Carraro, Amedeo
A1 Gastaldon, Fiorella
A1 Nordio, Maurizio
A1 Kumar-Singh, Samir
A1 Abedini, Mahsa
A1 Boffetta, Paolo
A1 Rodríguez-Baño, Jesús
A1 Lazzarotto, Tiziana
A1 Viale, Pierluigi
A1 Tacconelli, Evelina
A1 On Behalf Of The Orchestra Study Group Workpackage, 
K1 COVID-19
K1 antibody response
K1 mRNA vaccines
K1 serology
K1 solid organ transplantation
AB Previous studies assessing the antibody response (AbR) to mRNA COVID-19 vaccines in solid organ transplant (SOT) recipients are limited by short follow-up, hampering the analysis of AbR kinetics. We present the ORCHESTRA SOT recipients cohort assessed for AbR at first dose (t0), second dose (t1), and within 3 ± 1 month (t2) after the first dose. We analyzed 1062 SOT patients (kidney, 63.7%; liver, 17.4%; heart, 16.7%; and lung, 2.5%) and 5045 health care workers (HCWs). The AbR rates in the SOTs and HCWs were 52.3% and 99.4%. The antibody levels were significantly higher in the HCWs than in the SOTs (p
SN 2076-2607
YR 2022
FD 2022-05-12
LK http://hdl.handle.net/10668/21436
UL http://hdl.handle.net/10668/21436
LA en
DS RISalud
RD Apr 10, 2025